Panagora Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Panagora Asset Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,142	Closed	-$10K	–	2826
2021 Q2	$10K	Sell	1,142 -3,885	-77%	-$22.6K	﹤0.01%	2287
2021 Q1	$25K	Buy	+5,027	New	+$24.3K	﹤0.01%	2288
2016 Q2	–	Sell	-101,673	Closed	-$351K	–	2371
2016 Q1	$351K	Buy	101,673 +26,670	+36%	+$94.2K	﹤0.01%	1467
2015 Q4	$255K	Buy	+75,003	New	+$348K	﹤0.01%	1513
2015 Q2	–	Sell	-3,895	Closed	-$28K	–	2493
2015 Q1	$28K	Buy	+3,895	New	+$26.8K	﹤0.01%	2161
2014 Q2	–	Sell	-13,150	Closed	-$244K	–	2409
2014 Q1	$244K	Buy	+13,150	New	+$251K	﹤0.01%	1670

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Panagora Asset Management's KIN Position: Q3 2021 in Review

Panagora Asset Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 1,142 shares — an estimated $10K sold.

Panagora Asset Management first reported a position in KIN in Q1 2014 and held it in 6 quarters. The position peaked at $351K in Q1 2016. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Panagora Asset Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 1,142 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $10K.
Panagora Asset Management first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 6 quarters.
Panagora Asset Management's Kindred Biosciences, Inc. position peaked at $351K in Q1 2016.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.